Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the EverfLex NitInol STent System Post Approval Study

NCT01680835 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT01680835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01680835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the EverfLex NitInol STent System Post Approval Study
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Completed
Start date
January 14, 2013
Completion date
February 4, 2019
Enrollment
108 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

lower extremity arterial disease, peripheral arterial disease